Symbols / IBO $0.64 +8.36% Impact BioMedical Inc.

Healthcare • Biotechnology • United States • ASE
IBO Chart
About

Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. It also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, the company develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use as health supplements and medications. Further, it is developing 3F (functional fragrance formulation), a formulation of botanical ingredients. Impact BioMedical Inc. was incorporated in 2018 and is based in Houston, Texas. Impact BioMedical Inc. operates as a subsidiary of DSS BioHealth Security, Inc

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 69.01M
Enterprise Value 66.62M Income -11.84M Sales 32.00K
Book/sh 0.12 Cash/sh 3000.00 Dividend Yield —
Payout 0.00% Employees 2 IPO —
P/E — Forward P/E — PEG —
P/S 2156.42 P/B 5.29 P/C —
EV/EBITDA -21.32 EV/Sales 2081.94 Quick Ratio 0.01
Current Ratio 0.35 Debt/Eq — LT Debt/Eq —
EPS (ttm) -0.38 EPS next Y — EPS Growth —
Revenue Growth — Earnings — ROA -14.16%
ROE -104.16% ROIC — Gross Margin 0.00%
Oper. Margin -165.43% Profit Margin 0.00% Shs Outstand 107.82M
Shs Float 106.83M Short Float 11.22% Short Ratio 0.12
Short Interest — 52W High 1.95 52W Low 0.36
Beta — Avg Volume 4.49M Volume 192.33K
Target Price — Recom None Prev Close $0.59
Price $0.64 Change 8.36%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.64
Latest analyst target
3. DCF / Fair value
$-0.25
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.64
Low
—
High
—
Mean
—
News
RSS: Latest IBO news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-27 MACKO TODD D. Chief Financial Officer — 45,000 $0.56 $25,330
2026-03-23 GRADY JASON Director — 50,000 $0.65 $32,505
2025-05-27 DSS INC. Beneficial Owner of more than 10% of a Class of Security — 161,000 $0.54 $88,006
2025-04-04 CHAN HENG FAI AMBROSE Director and Beneficial Owner of more than 10% of a Class of Security — 1,689,693 $0.46 $996,397
2025-04-04 DSS INC. Beneficial Owner of more than 10% of a Class of Security — 890,800 $0.95 $845,013
2025-04-03 CHAN HENG FAI AMBROSE Director — 351,555 $0.50 $174,020
2025-04-01 CHAN HENG FAI AMBROSE Director and Beneficial Owner of more than 10% of a Class of Security — 2,526,918 $0.82 $2,199,273
2025-03-27 DSS INC. Beneficial Owner of more than 10% of a Class of Security — 605,620 $2.20 $2,726,169
2025-03-20 DSS INC. Beneficial Owner of more than 10% of a Class of Security — 200 $2.08 $416
2025-03-20 DSS INC. Beneficial Owner of more than 10% of a Class of Security — 53,300 $2.08 $110,880
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.03
0.00
0.00
-100.00%
0.05
Operating Revenue
0.03
0.00
0.00
-100.00%
0.05
Cost Of Revenue
0.42
0.00
—
—
Reconciled Cost Of Revenue
0.42
0.00
—
—
Gross Profit
-0.39
0.00
—
—
Operating Expense
3.88
+14.16%
3.40
-15.67%
4.03
+16.62%
3.45
Research And Development
0.34
+22.30%
0.28
-83.50%
1.69
+37.44%
1.23
Selling General And Administration
1.98
+8.04%
1.83
+65.67%
1.10
+5.44%
1.05
Selling And Marketing Expense
0.02
-96.21%
0.63
+873.85%
0.07
-80.00%
0.33
General And Administrative Expense
1.95
+63.21%
1.20
+15.11%
1.04
-0.76%
1.05
Other Gand A
1.88
+61.34%
1.16
+12.03%
1.04
-0.76%
1.05
Other Operating Expenses
0.42
+143.86%
0.17
+43.70%
0.12
+75.00%
0.07
Total Expenses
4.30
+26.64%
3.40
-15.67%
4.03
+16.62%
3.45
Operating Income
-4.27
-25.70%
-3.40
+15.67%
-4.03
-18.33%
-3.40
Total Operating Income As Reported
-4.28
+85.11%
-28.75
-613.83%
-4.03
-18.33%
-3.40
EBITDA
-12.51
+44.52%
-22.55
-693.28%
-2.84
+54.88%
-6.30
Normalized EBITDA
-12.50
-545.95%
2.80
+198.59%
-2.84
-29.17%
-2.20
Reconciled Depreciation
1.15
+2.32%
1.12
-0.09%
1.12
+0.63%
1.11
EBIT
-13.66
+42.31%
-23.67
-497.33%
-3.96
+46.55%
-7.41
Total Unusual Items
-0.01
+99.95%
-25.36
0.00
+100.00%
-4.10
Total Unusual Items Excluding Goodwill
-0.01
+99.95%
-25.36
0.00
+100.00%
-4.10
Special Income Charges
-0.01
+99.95%
-25.36
0.00
+100.00%
-4.10
Impairment Of Capital Assets
0.00
-100.00%
25.36
0.00
—
Write Off
—
—
0.00
-100.00%
4.10
Net Income
-11.84
+52.09%
-24.71
-469.83%
-4.34
+38.51%
-7.05
Pretax Income
-14.45
+41.59%
-24.74
-461.31%
-4.41
+44.05%
-7.88
Net Non Operating Interest Income Expense
-0.78
+25.86%
-1.05
-144.08%
-0.43
+1.60%
-0.44
Interest Expense Non Operating
0.79
-25.54%
1.06
+139.86%
0.44
-3.90%
0.46
Net Interest Income
-0.78
+25.86%
-1.05
-144.08%
-0.43
+1.60%
-0.44
Interest Expense
0.79
-25.54%
1.06
+139.86%
0.44
-3.90%
0.46
Interest Income Non Operating
0.01
+0.00%
0.01
+0.00%
0.01
-45.83%
0.02
Interest Income
0.01
+0.00%
0.01
+0.00%
0.01
-45.83%
0.02
Other Income Expense
-9.40
+53.67%
-20.29
-39115.38%
0.05
+101.29%
-4.03
Other Non Operating Income Expenses
-9.39
-285.24%
5.07
+9646.15%
0.05
-21.21%
0.07
Tax Provision
-2.58
-7918.18%
0.03
0.00
+100.00%
-0.62
Tax Rate For Calcs
0.00
-14.76%
0.00
0.00
-100.00%
0.00
Tax Effect Of Unusual Items
-0.00
+99.96%
-5.32
0.00
+100.00%
-0.32
Net Income Including Noncontrolling Interests
-11.87
+52.08%
-24.77
-462.06%
-4.41
+39.26%
-7.25
Net Income From Continuing Operation Net Minority Interest
-11.84
+52.09%
-24.71
-469.83%
-4.34
+38.51%
-7.05
Net Income From Continuing And Discontinued Operation
-11.84
+52.09%
-24.71
-469.83%
-4.34
+38.51%
-7.05
Net Income Continuous Operations
-11.87
+52.08%
-24.77
-462.06%
-4.41
+39.26%
-7.25
Minority Interests
0.03
-48.39%
0.06
-12.68%
0.07
-65.20%
0.20
Normalized Income
-11.83
-152.91%
-4.68
-7.86%
-4.34
-32.40%
-3.27
Net Income Common Stockholders
-11.84
+52.09%
-24.71
-469.83%
-4.34
+38.51%
-7.05
Diluted EPS
—
-2.30
-3185.71%
-0.07
+88.59%
-0.61
Basic EPS
—
-2.30
-3185.71%
-0.07
+88.59%
-0.61
Basic Average Shares
—
10.76
-82.15%
60.25
+424.00%
11.50
Diluted Average Shares
—
10.76
-82.15%
60.25
+424.00%
11.50
Diluted NI Availto Com Stockholders
-11.84
+52.09%
-24.71
-469.83%
-4.34
+38.51%
-7.05
Amortization
—
—
1.12
+0.63%
1.11
Amortization Of Intangibles Income Statement
—
—
1.12
+0.63%
1.11
Depreciation Amortization Depletion Income Statement
1.15
+2.32%
1.12
-0.09%
1.12
+0.63%
1.11
Depreciation And Amortization In Income Statement
1.15
+2.32%
1.12
-0.09%
1.12
+0.63%
1.11
Gain On Sale Of PPE
-0.01
—
—
—
Rent And Landing Fees
0.07
+131.25%
0.03
0.00
—
Rent Expense Supplemental
0.07
+131.25%
0.03
0.00
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
17.41
-14.22%
20.29
-54.54%
44.63
-4.01%
46.50
Current Assets
0.41
-83.21%
2.45
+637.35%
0.33
+172.13%
0.12
Cash Cash Equivalents And Short Term Investments
0.00
-99.85%
2.00
+199800.00%
0.00
-50.00%
0.00
Cash And Cash Equivalents
0.00
-99.85%
2.00
+199800.00%
0.00
-50.00%
0.00
Cash Financial
0.00
-99.85%
2.00
+199800.00%
0.00
—
Receivables
0.20
+10.33%
0.18
-44.41%
0.33
+1968.75%
0.02
Accounts Receivable
0.01
0.00
—
—
Other Receivables
—
—
0.13
—
Inventory
0.06
0.00
—
—
Finished Goods
0.06
0.00
—
—
Prepaid Assets
0.14
-46.42%
0.27
0.00
-100.00%
0.06
Other Current Assets
—
—
—
0.10
Total Non Current Assets
16.99
-4.75%
17.84
-59.73%
44.30
-4.47%
46.38
Net PPE
0.00
-100.00%
0.02
-94.08%
0.29
+3.99%
0.28
Gross PPE
0.00
-100.00%
0.03
-89.76%
0.29
+6.16%
0.28
Accumulated Depreciation
0.00
+100.00%
-0.01
-116.67%
-0.01
0.00
Machinery Furniture Equipment
0.00
-100.00%
0.03
+0.00%
0.03
+20.00%
0.03
Construction In Progress
—
0.00
-100.00%
0.26
+4.78%
0.25
Goodwill And Other Intangible Assets
16.99
-4.57%
17.81
-59.54%
44.01
-2.47%
45.13
Goodwill
—
0.00
-100.00%
25.09
+0.00%
25.09
Other Intangible Assets
16.99
-4.57%
17.81
-5.88%
18.92
-5.56%
20.03
Investments And Advances
—
—
0.00
-100.00%
0.78
Long Term Equity Investment
—
—
—
0.78
Other Investments
—
—
0.00
-100.00%
0.78
Other Non Current Assets
—
—
—
0.78
Total Liabilities Net Minority Interest
1.85
-85.83%
13.05
-20.27%
16.37
+18.39%
13.83
Current Liabilities
1.16
-88.12%
9.79
-25.51%
13.14
+24.01%
10.59
Payables And Accrued Expenses
1.16
+28.11%
0.91
-14.60%
1.06
+76.41%
0.60
Payables
0.97
+35.76%
0.71
-14.30%
0.83
+54.36%
0.54
Accounts Payable
0.35
+10.51%
0.31
-62.26%
0.83
+54.36%
0.54
Current Accrued Expenses
0.19
+0.00%
0.19
-15.65%
0.23
+265.08%
0.06
Current Debt And Capital Lease Obligation
—
8.88
-26.47%
12.07
+20.85%
9.99
Current Debt
—
8.88
-26.47%
12.07
+20.85%
9.99
Total Non Current Liabilities Net Minority Interest
0.69
-78.95%
3.27
+1.02%
3.23
+0.00%
3.23
Non Current Deferred Liabilities
0.69
-78.95%
3.27
+1.02%
3.23
+0.00%
3.23
Non Current Deferred Taxes Liabilities
0.69
-78.95%
3.27
+1.02%
3.23
+0.00%
3.23
Stockholders Equity
12.61
+196.06%
4.26
-83.11%
25.22
-14.67%
29.56
Common Stock Equity
12.61
+200.29%
4.20
-83.31%
25.16
-14.87%
29.56
Capital Stock
0.10
+47.89%
0.07
+1.43%
0.07
+0.00%
0.07
Common Stock
0.10
+854.55%
0.01
+10.00%
0.01
-85.71%
0.07
Preferred Stock
0.00
-100.00%
0.06
+0.00%
0.06
0.00
Share Issued
104.62
+809.44%
11.50
+0.05%
11.50
+0.00%
11.50
Ordinary Shares Number
104.62
+809.44%
11.50
+0.05%
11.50
+0.00%
11.50
Additional Paid In Capital
62.01
+48.15%
41.86
+9.82%
38.11
+0.00%
38.11
Retained Earnings
-49.51
-31.43%
-37.67
-190.63%
-12.96
-50.27%
-8.62
Minority Interest
2.95
-1.07%
2.98
-2.04%
3.04
-2.28%
3.11
Total Equity Gross Minority Interest
15.55
+114.94%
7.24
-74.39%
28.26
-13.49%
32.67
Total Capitalization
12.61
+196.06%
4.26
-83.11%
25.22
-14.67%
29.56
Working Capital
-0.75
+89.76%
-7.34
+42.70%
-12.80
-22.28%
-10.47
Invested Capital
12.61
-3.58%
13.08
-64.88%
37.24
-5.85%
39.55
Total Debt
—
8.88
-26.47%
12.07
+20.85%
9.99
Net Debt
—
6.88
-43.02%
12.07
+20.86%
9.99
Net Tangible Assets
-4.38
+67.64%
-13.55
+27.90%
-18.79
-20.70%
-15.57
Tangible Book Value
-4.38
+67.78%
-13.61
+27.81%
-18.85
-21.09%
-15.57
Current Notes Payable
0.00
-100.00%
8.88
-26.47%
12.07
+20.85%
9.99
Dueto Related Parties Current
0.62
+55.64%
0.40
—
—
Investments In Other Ventures Under Equity Method
—
—
—
0.78
Non Current Note Receivables
0.00
-100.00%
0.02
0.00
-100.00%
0.19
Notes Receivable
0.20
+7.61%
0.18
-9.36%
0.20
+1168.75%
0.02
Preferred Stock Equity
—
0.06
+0.00%
0.06
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-1.89
+33.78%
-2.85
-0.11%
-2.85
-27.16%
-2.24
Cash Flow From Continuing Operating Activities
-1.89
+33.78%
-2.85
-0.11%
-2.85
-27.16%
-2.24
Net Income From Continuing Operations
-11.87
+52.08%
-24.77
-462.06%
-4.41
+39.26%
-7.25
Depreciation Amortization Depletion
1.15
+2.32%
1.12
-0.09%
1.12
+0.63%
1.11
Amortization Cash Flow
—
—
—
1.11
Depreciation And Amortization
1.15
+2.32%
1.12
-0.09%
1.12
+0.63%
1.11
Amortization Of Intangibles
—
—
—
1.11
Other Non Cash Items
10.37
+359.08%
-4.00
—
—
Stock Based Compensation
0.01
-31.58%
0.02
0.00
—
Asset Impairment Charge
0.42
-98.35%
25.36
0.00
-100.00%
4.10
Deferred Tax
-2.58
-7918.18%
0.03
0.00
+100.00%
-0.62
Deferred Income Tax
-2.58
-7918.18%
0.03
0.00
+100.00%
-0.62
Operating Gains Losses
0.01
—
—
—
Gain Loss On Sale Of PPE
0.01
0.00
—
—
Change In Working Capital
0.60
+198.68%
-0.61
-239.45%
0.44
+3.56%
0.42
Change In Receivables
-0.00
-100.78%
0.13
+200.00%
-0.13
0.00
Changes In Account Receivables
-0.00
-100.78%
0.13
—
—
Change In Inventory
0.01
0.00
—
—
Change In Prepaid Assets
0.13
+147.55%
-0.27
-354.81%
0.10
+273.33%
-0.06
Change In Payables And Accrued Expense
0.47
+199.36%
-0.47
-202.39%
0.46
-4.37%
0.48
Change In Accrued Expense
-0.00
+94.29%
-0.04
-120.96%
0.17
+192.98%
0.06
Change In Payable
0.47
+207.80%
-0.44
-248.81%
0.29
-30.90%
0.42
Change In Account Payable
0.47
+207.80%
-0.44
-248.81%
0.29
-30.90%
0.42
Investing Cash Flow
0.00
+50.00%
0.00
+113.33%
-0.01
+95.70%
-0.35
Cash Flow From Continuing Investing Activities
0.00
+50.00%
0.00
+113.33%
-0.01
+95.70%
-0.35
Net PPE Purchase And Sale
—
0.00
+100.00%
-0.02
+93.48%
-0.28
Purchase Of PPE
—
0.00
+100.00%
-0.02
+93.48%
-0.28
Capital Expenditure
—
—
-0.02
+93.48%
-0.28
Net Investment Purchase And Sale
—
—
0.00
+100.00%
-0.07
Purchase Of Investment
—
—
0.00
+100.00%
-0.07
Net Other Investing Changes
0.00
+50.00%
0.00
-33.33%
0.00
+137.50%
-0.01
Financing Cash Flow
-0.11
-102.25%
4.85
+69.28%
2.87
+12.49%
2.55
Cash Flow From Continuing Financing Activities
-0.11
-102.25%
4.85
+69.28%
2.87
+12.49%
2.55
Net Issuance Payments Of Debt
-0.11
-109.70%
1.12
-60.77%
2.87
+12.49%
2.55
Issuance Of Debt
0.18
-83.63%
1.12
-60.77%
2.87
+12.49%
2.55
Repayment Of Debt
-0.29
0.00
—
—
Short Term Debt Issuance
0.18
-83.63%
1.12
-60.77%
2.87
+12.49%
2.55
Short Term Debt Payments
-0.29
0.00
—
—
Net Short Term Debt Issuance
-0.11
-109.70%
1.12
-60.77%
2.87
+12.49%
2.55
Net Common Stock Issuance
0.00
-100.00%
3.73
0.00
—
Changes In Cash
-2.00
-199.90%
2.00
+199900.00%
-0.00
+97.73%
-0.04
Beginning Cash Position
2.00
+199800.00%
0.00
-50.00%
0.00
-95.65%
0.05
End Cash Position
0.00
-99.85%
2.00
+199800.00%
0.00
-50.00%
0.00
Free Cash Flow
-1.89
+33.78%
-2.85
+0.52%
-2.87
-13.94%
-2.52
Interest Paid Supplemental Data
0.00
0.00
—
—
Common Stock Issuance
0.00
-100.00%
3.73
0.00
—
Issuance Of Capital Stock
0.00
-100.00%
3.73
0.00
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category